Bristol-Myers Squibb Exec Says Eliquis Sales In Q4 Will Be Impacted By The Upcoming LOE In Europe
https://event.choruscall.com/mediaframe/webcast.html?webcastid=GlsfwVZY
Share
Why It Matters
Bristol-Myers Squibb said its Eliquis blood thinner will sell less soon. This happens because a cheaper copy version can be made in Europe.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.